The failure of the ACCLAIM trial is due to an irrational technology. [electronic resource]
- International journal of cardiology Mar 2010
- 304-5 p. digital
Publication Type: Letter
1874-1754
10.1016/j.ijcard.2008.10.001 doi
Chronic Disease Heart Failure--diagnosis Humans Oxidants, Photochemical--therapeutic use Oxidative Stress--physiology Ozone--therapeutic use Randomized Controlled Trials as Topic--methods Treatment Failure